CREB inhibitor inhibited human B-lymphoma cell proliferation. (IMAGE)
Caption
(A) Cell morphology under the microscope (left), cell number, and CCK8 levels indicate cell viability (right). (B) Flow cytometer analysis showed that human B-lymphoma cells underwent apoptosis after CREB inhibitor treatment. (D) Western blot experiment demonstrates the efficacy of CREB antibody; the motifs of the top 4 CREB-binding genomic loci. (E) Percentage of CREB-binding genomic loci. (F) Treatment with CREB inhibitor for xenograft testicular models of DLBCL.
Credit
Genes & Diseases
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND